TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs

Oncogene

Volumn 32, Issue 39, 2013, Pages 4646-4655

  Ballarino, M ^a   Jobert, L ^a   Dembele D ^a   De La Grange, P ^b   Auboeuf, D ^c   Tora, L ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b GenoSplice Technology   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

FUS EWS TAF15 (FET) proteins; miRNAs; neuroblastoma; neuronal differentiation; proliferation; transcription

Indexed keywords

DNA BINDING PROTEIN; MICRORNA; MICRORNA 17; MICRORNA 20A; PROTEIN TAF 15; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMPEDANCE; INTRON RETENTION; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NORTHERN BLOTTING; NUCLEIC ACID METABOLISM; ONCOGENE C MYB; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENES, REPORTER; HELA CELLS; HUMANS; MICRORNAS; NEOPLASM PROTEINS; NEUROBLASTOMA; NEUROGENESIS; NEURONS; RNA INTERFERENCE; TATA-BINDING PROTEIN ASSOCIATED FACTORS;

EID: 84884907673     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.490     Document Type: Article

References (33)

1. Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L. hTAF(II)68, a novel RNA/ssDNAbinding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 1996; 15: 50225031.
2. Butler JE, Kadonaga JT. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 2002; 16: 25832592.
3. Tora L. A unified nomenclature for TATA box binding protein (TBP)-associated factors (TAFs) involved in RNA polymerase II transcription. Genes Dev 2002; 16: 673675.
4. Sankar S, Lessnick SL. Promiscuous partnerships in Ewings sarcoma. Cancer Genet 2011; 204: 351365.
5. Bertolotti A, Bell B, Tora L. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene 1999; 18: 80008010.
6. Law WJ, Cann KL, Hicks GG. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic 2006; 5: 814.
7. Jobert L, Argentini M, Tora L. PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function. Exp Cell Res 2009; 315: 12731286.
8. Jobert L, Pinzon N, Van Herreweghe E, Jady BE, Guialis A, Kiss T et al. Human U1 snRNA forms a new chromatin-associated snRNP with TAF15. EMBO Rep 2009; 10: 494500.
9. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 2012; 13: 271282.
10. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235240.
11. McKinsey EL, Parrish JK, Irwin AE, Niemeyer BF, Kern HB, Birks DK et al. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. Oncogene 2011; 30: 49104920.
12. De Vito C, Riggi N, Suva ML, Janiszewska M, Horlbeck J, Baumer K et al. Let-7a is a direct EWS-FLI-1 target implicated in Ewings sarcoma development. PLoS One 2011; 6: e23592.
13. de la Grange P, Dutertre M, Martin N, Auboeuf D. FAST DB: a website resource for the study of the expression regulation of human gene products. Nucleic Acids Res 2005; 33: 42764284.
14. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 2011; 39: D163D169.
15. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133: 217222.
16. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 15011512.
17. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007; 9: 775787.
18. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28: 21672174.
19. Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 2008; 68: 81918194.
20. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008; 3: e2236.
21. Beveridge NJ, Tooney PA, Carroll AP, Tran N, Cairns MJ. Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation. Cell signal 2009; 21: 18371845.
22. Thiele CJ, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 1985; 313: 404406.
23. Rossi A, Granata F, Augusti-Tocco G, Canu N, Levi A, Possenti R. Expression in murine and human neuroblastoma cell lines of VGF, a tissue specific protein. Int J Dev Neurosci 1992; 10: 527534.
24. Spitzer JI, Ugras S, Runge S, Decarolis P, Antonescu C, Tuschl T et al. mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. Genes, Chromosomes Cancer 2011; 50: 338347.
25. Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, Amiot F et al. An openaccess long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Res 2006; 34: e87.
26. Guil S, Caceres JF. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nature structural & molecular biology. Nat Struct Mol Biol 2007; 14: 591596.
27. Hoell JI, Larsson E, Runge S, Nusbaum JD, Duggimpudi S, Farazi TA et al. RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol 2011; 18: 14281431.
28. Chaulk SG, Thede GL, Kent OA, Xu Z, Gesner EM, Veldhoen RA et al. Role of primiRNA tertiary structure in miR-17B92 miRNA biogenesis. RNA biol 2011; 8: 11051114.
29. Blechingberg J, Holm IE, Nielsen AL. Characterization and expression analysis in the developing embryonic brain of the porcine FET family: FUS, EWS, and TAF15. Gene 2012; 493: 2735.
30. Andersson MK, Stahlberg A, Arvidsson Y, Olofsson A, Semb H, Stenman G et al. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell typespecific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 2008; 9: 37.
31. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003; 3: 639649.
32. Pall GS, Hamilton AJ. Improved northern blot method for enhanced detection of small RNA. Nat Protoc 2008; 3: 10771084.
33. Lee Y, Kim VN. In vitro and in vivo assays for the activity of Drosha complex. Methods Enzymol 2007; 427: 89106.